Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v5-FR
Language French French
Date Updated 2022-05-13 2022-05-13
Drug Identification Number 02172771 02172771
Brand name OMNISCAN OMNISCAN
Common or Proper name Gadodiamide injection USP Gadodiamide injection USP
Company Name GE HEALTHCARE CANADA INC GE HEALTHCARE CANADA INC
Ingredients GADODIAMIDE GADODIAMIDE
Strength(s) 287MG 287MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 10 mL 10 mL
ATC code V08CA V08CA
ATC description MAGNETIC RESONANCE IMAGING CONTRAST MEDIA MAGNETIC RESONANCE IMAGING CONTRAST MEDIA
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2022-07-15 2022-07-15
Actual start date
Estimated end date
Actual end date 2022-05-13 2022-05-13
Shortage status Avoided shortage Avoided shortage
Tier 3 Status No No
Company comments No longer anticipate drug shortage No longer anticipate drug shortage
Health Canada comments